Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
BörsenkürzelSNN
Name des UnternehmensSmith & Nephew PLC
IPO-datumSep 18, 2087
CEONath (Deepak S)
Anzahl der mitarbeiter17349
WertpapierartDepository Receipt
GeschäftsjahresendeSep 18
AddresseBuilding 5
StadtWATFORD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlWD18 8YE
Telefon4401923477100
Websitehttps://www.smith-nephew.com/
BörsenkürzelSNN
IPO-datumSep 18, 2087
CEONath (Deepak S)